Deutsche Bank Maintains Hold on GoodRx Holdings, Lowers Price Target to $20
Deutsche Bank analyst George Hill maintains GoodRx Holdings (NASDAQ:GDRX) with a Hold and lowers the price target from $25 to $20.
Mid-Afternoon Market Update: U.S. Stocks Extend Losses; Dow Dips 750 Points
U.S. stocks extended losses toward the end of trading, with the Dow Jones tumbling 750 points on Tuesday.
GoodRx Plunges As Q4 Fall Short Of Expectations, Analysts Cut Price Target
Consumer-focused digital healthcare, GoodRx Holdings Inc (NASDAQ: GDRX) shares are plunging after the company's
Mid-Day Market Update: Crude Oil Jumps 9%; GoodRx Holdings Shares Plunge
U.S. stocks remained lower midway through trading on Tuesday, amid the ongoing Russia-Ukraine conflict.
36 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Avenue Therapeutics, Inc. (NASDAQ: ATXI) climbed 193% to $0.9962 after jumping 36% on Monday.
Why GoodRX Shares Are Plummeting Today
GoodRx Holdings Inc (NASDAQ: GDRX) is plunging Tuesday after the company reported worse-than-expected fourth-quarter financial results and issued guidance below estimates.
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's trading, 98 companies set new 52-week lows.
